; (iii) whether the foreign person engaging in such transaction— (I) adheres to United States standards of corporate governance (including commitments to transparency and disclosure, independent members of the board of directors, independent audit committees, and equitable treatment of shareholders); (II) adheres to United States laws and practices; and (III) is a foreign person of a country whose government has adequately engaged with the Securities and Exchange Commission and the Public Company Accounting Oversight Board in order to promote and ensure adequate transparency; and (iv) whether the foreign person engaging in such transaction will likely operate on a commercial basis if such transaction is completed, including with regard to— (I) where to export; (II) where to process; (III) the participation of United States citizens in its operations in the United States and elsewhere; (IV) the impact of the investment on productivity and industrial efficiency in the United States; (V) support of on-going innovation, research, and development in the United States; (VI) sourcing patterns; and (VII) the appropriate level of capital expenditures to maintain the United States business in a globally competitive position; and (G) such other factors as the Committee determines appropriate. (2) Determining net benefit In making a net benefit determination under subsection (b)(1)(A)(ii)— (A) judgments will be made both in measuring the effects of a proposed or pending transaction in relation to the relevant individual factors under paragraph (1) and in measuring the aggregate net effect after offsetting the negative effects, if any, against the positive ones; and (B) a proposed or pending transaction will be determined to be of net benefit to the United States when the aggregate net effect is positive, regardless of its extent over the short- and long-term. (3) Right to appeal